VWF and COVID-19: Hypercoagulation among COVID-19 patients involves increased blood levels of fibrinogen, thrombin, thrombin-anti-thrombin complex, activated platelets, von Willebrand factor (vWF), and circulating endothelial cells (Kichloo et al., 2020; Mazzeffi et al., 2021).